Device Management in Heart Failure.

about

Device Management in Heart Failure.

Item

http://www.wikidata.org/entity/Q47632456

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Device Management in Heart Failure.

@en

Device Management in Heart Failure.

@nl

type

Item

label

Device Management in Heart Failure.

@en

Device Management in Heart Failure.

@nl

prefLabel

Device Management in Heart Failure.

@en

Device Management in Heart Failure.

@nl

P1476

Device Management in Heart Failure.

@en

P2093

Brett G Angel

http://www.w3.org/2001/XMLSchema#string

Heath Saltzman

http://www.w3.org/2001/XMLSchema#string

Luke S Kusmirek

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients.

Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Bradycardia and syncope as a presentation of cardiac allograft rejection involving the conducting system.

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

P2888

s11886-017-0914-2

P304

114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-017-0914-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28948481

http://www.w3.org/2001/XMLSchema#string